ERD-1233: A potent and orally active oestrogen receptor PROTAC degrader for treating ER+ breast cancer

Eur J Surg Oncol. 2024 Dec 27;51(3):109567. doi: 10.1016/j.ejso.2024.109567. Online ahead of print.

Authors

Dhivya Viswanathan¹, Rajakumar Govindasamy²

Affiliations

¹ Department of Orthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600077, Tamilnadu, India.
² Department of Orthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600077, Tamilnadu, India. Electronic address: [email protected].

PMID: 39742721
DOI: 10.1016/j.ejso.2024.109567

No abstract available

Publication types

Letter